课题基金 / 基金详情

COVID supplement: Tetramer Research & Development

COVID supplement: Tetramer Research & Development
新冠肺炎补充剂:四聚体研究
批准号:
10678174
负责人:
JOHN ALTMAN
金额:
$20.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-03-21 至 2027-03-20

项目摘要

项目成果

JOHN ALTMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The NIH Tetramer Core Facility provides valuable resources to the research community that enable cutting edge research in basic immunology (such as SARS-CoV-2) and a wide variety of infectious disease areas via production and distribution of class I, class II and CD1 reagents. The reagents are being applied to studies of antigen processing and presentation, T cell activation, T cell responses against microbial pathogens or tumors, and T cell-mediated exacerbation or amelioration of immune-mediated diseases. This contract conducts research and development that would enhance the quality, functionality (e.g., sensitivity), and breadth of available tetramer reagents and decrease production time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task Order B-5_75N93022F00002; 09/19/2022-03/20/2023; $18,543.00.
  • 批准号:
    10703781
  • 项目类别:
  • 资助金额:
    $1.85万
  • 财政年份:
    2020
  • 负责人:
    JOHN ALTMAN
  • 依托单位:
NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)
  • 批准号:
    10376128
  • 项目类别:
  • 资助金额:
    $200.18万
  • 财政年份:
    2020
  • 负责人:
    JOHN ALTMAN
  • 依托单位:
NIH TETRAMER CORE FACILITY (HIV/AIDS)
  • 批准号:
    10376127
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2020
  • 负责人:
    JOHN ALTMAN
  • 依托单位:
NIH Tetramer Core Facility
  • 批准号:
    10812213
  • 项目类别:
  • 资助金额:
    $148.79万
  • 财政年份:
    2020
  • 负责人:
    JOHN ALTMAN
  • 依托单位:
海外基金